191 related articles for article (PubMed ID: 24921912)
1. Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model.
Chiu B; Coburn J; Pilichowska M; Holcroft C; Seib FP; Charest A; Kaplan DL
Br J Cancer; 2014 Aug; 111(4):708-15. PubMed ID: 24921912
[TBL] [Abstract][Full Text] [Related]
2. Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma.
Taylor JS; Yavuz B; Zeki J; Wood L; Ikegaki N; Coburn J; Harrington K; Shimada H; Kaplan DL; Chiu B
Surgery; 2020 Jun; 167(6):969-977. PubMed ID: 32122657
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model.
Ornell KJ; Taylor JS; Zeki J; Ikegaki N; Shimada H; Coburn JM; Chiu B
Cancer Med; 2020 Apr; 9(8):2891-2903. PubMed ID: 32096344
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded silk films: drug-silk interactions and in vivo performance in human orthotopic breast cancer.
Seib FP; Kaplan DL
Biomaterials; 2012 Nov; 33(33):8442-50. PubMed ID: 22922025
[TBL] [Abstract][Full Text] [Related]
5. Focal therapy of neuroblastoma using silk films to deliver kinase and chemotherapeutic agents in vivo.
Seib FP; Coburn J; Konrad I; Klebanov N; Jones GT; Blackwood B; Charest A; Kaplan DL; Chiu B
Acta Biomater; 2015 Jul; 20():32-38. PubMed ID: 25861948
[TBL] [Abstract][Full Text] [Related]
6. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
[TBL] [Abstract][Full Text] [Related]
7. Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth.
Zeki J; Taylor JS; Yavuz B; Coburn J; Ikegaki N; Kaplan DL; Chiu B
Surgery; 2018 Oct; 164(4):909-915. PubMed ID: 30061039
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression.
Taylor JS; Zeki J; Ornell K; Coburn J; Shimada H; Ikegaki N; Chiu B
J Pediatr Surg; 2019 Jun; 54(6):1192-1197. PubMed ID: 30879743
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.
Pastorino F; Di Paolo D; Piccardi F; Nico B; Ribatti D; Daga A; Baio G; Neumaier CE; Brignole C; Loi M; Marimpietri D; Pagnan G; Cilli M; Lepekhin EA; Garde SV; Longhi R; Corti A; Allen TM; Wu JJ; Ponzoni M
Clin Cancer Res; 2008 Nov; 14(22):7320-9. PubMed ID: 19010847
[TBL] [Abstract][Full Text] [Related]
10. Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment.
Coburn J; Harris J; Zakharov AD; Poirier J; Ikegaki N; Kajdacsy-Balla A; Pilichowska M; Lyubimov AV; Shimada H; Kaplan DL; Chiu B
Int J Cancer; 2017 Feb; 140(3):726-735. PubMed ID: 27770551
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma.
Lautz TB; Naiditch JA; Clark S; Chu F; Madonna MB
J Pediatr Surg; 2012 Jun; 47(6):1267-71. PubMed ID: 22703804
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment.
Yavuz B; Zeki J; Coburn JM; Ikegaki N; Levitin D; Kaplan DL; Chiu B
J Control Release; 2018 Sep; 285():162-171. PubMed ID: 30018030
[TBL] [Abstract][Full Text] [Related]
13. Focal drug administration via heparin-containing cryogel microcarriers reduces cancer growth and metastasis.
Newland B; Varricchio C; Körner Y; Hoppe F; Taplan C; Newland H; Eigel D; Tornillo G; Pette D; Brancale A; Welzel PB; Seib FP; Werner C
Carbohydr Polym; 2020 Oct; 245():116504. PubMed ID: 32718615
[TBL] [Abstract][Full Text] [Related]
14. Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma.
Sagnella SM; Trieu J; Brahmbhatt H; MacDiarmid JA; MacMillan A; Whan RM; Fife CM; McCarroll JA; Gifford AJ; Ziegler DS; Kavallaris M
Mol Cancer Ther; 2018 May; 17(5):1012-1023. PubMed ID: 29491149
[TBL] [Abstract][Full Text] [Related]
15. Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations.
Yavuz B; Zeki J; Taylor J; Harrington K; Coburn JM; Ikegaki N; Kaplan DL; Chiu B
J Pharm Sci; 2019 Aug; 108(8):2748-2755. PubMed ID: 30905702
[TBL] [Abstract][Full Text] [Related]
16. Enhanced therapeutic index of liposomal doxorubicin Myocet locally delivered by fibrin gels in immunodeficient mice bearing human neuroblastoma.
Viale M; Bertone V; Maric I; Cilli M; Emionite L; Bocchini V; Ponzoni M; Fontana V; De Luca F; Rocco M
Pharmacol Res; 2021 Jan; 163():105294. PubMed ID: 33217536
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome of
Corroyer-Dulmont A; Falzone N; Kersemans V; Thompson J; Allen DP; Able S; Kartsonaki C; Malcolm J; Kinchesh P; Hill MA; Vojnovic B; Smart SC; Gaze MN; Vallis KA
Radiother Oncol; 2017 Sep; 124(3):488-495. PubMed ID: 28595752
[TBL] [Abstract][Full Text] [Related]
18. Sustained delivery of vincristine inside an orthotopic mouse sarcoma model decreases tumor growth.
Harris JC; Coburn JM; Kajdacsy-Balla A; Kaplan DL; Chiu B
J Pediatr Surg; 2016 Dec; 51(12):2058-2062. PubMed ID: 27680598
[TBL] [Abstract][Full Text] [Related]
19. Carbon Dioxide-Generating PLG Nanoparticles for Controlled Anti-Cancer Drug Delivery.
Jang HJ; Jeong EJ; Lee KY
Pharm Res; 2018 Feb; 35(3):59. PubMed ID: 29427239
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of variables in local controlled release vincristine treatment in neuroblastoma.
Coburn JM; Harris J; Cunningham R; Zeki J; Kaplan DL; Chiu B
J Pediatr Surg; 2017 Dec; 52(12):2061-2065. PubMed ID: 28927981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
